Astellas UK has been suspended from the Association of the British Pharaceutial Industry over a serious breach of the groups code of practice (for its behaviour in marketing a cancer drug) according to a report in the Sunday Telegraph.
Is this likely to affect the supply or availability of Prograf which they also market? I suspect it will not have an affect but would be interested in views more informed than mine.
Written by
PeterP54
To view profiles and participate in discussions please or .
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.